Bates et al., 20191111 Bates JE, Amdur RJ, Morris CM, Hitchcock KE, Dziegielewski PT, Boyce BJ, et al. Curative-dose Chemoradiotherapy Versus Total Laryngectomy for Stage T3-T4 Squamous Cell Carcinoma of the Larynx. Am J Clin Onc. 2019;42:527-33.
|
11,010 |
OS-T3, OS-T4 |
Bussu et al., 20131616 Bussu F, Paludetti G, Almadori G, De Virgilio A, Galli J, Micciche F, et al. Comparison of total laryngectomy with surgical (cricohyoidopexy) and nonsurgical organ‐preservation modalities in advanced laryngeal squamous cell carcinomas: A multicenter retrospective analysis. Head Neck. 2013;35:554-561.
|
166 |
OS, DSS, Dysp |
Choi et al., 20161717 Choi YS, Park SG, Song EK, Cho SH, Park KU, et al. Comparison of the therapeutic effects of total laryngectomy and a larynx‐preservation approach in patients with T4a laryngeal cancer and thyroid cartilage invasion: A multicenter retrospective review. Head Neck. 2016;38:1271-7.
|
142 |
OS, OS-T4 |
Cocek et al., 20181818 Čoček A, Ambruš M, Dohnalová A, Chovanec M, Kubecová M, Licková K. Locally advanced laryngeal cancer: Total laryngectomy or primary non-surgical treatment? Oncol Lett. 2018;15:6701-8.
|
185 |
Rec |
Dyckhoff et al., 20171919 Dyckhoff G, Plinkert PK, Ramroth H. A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients. BMC Cancer. 2017;17:609.
|
268 |
OS, OS-T4 |
Dziegielewski et al., 20122020 Dziegielewski PT, O'connell DA, Klein M, Fung C, Singh P, Mlynarek A, et al. Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival. J Otolaryngol Head Neck Surg. 2012;41:S56-S64.
|
258 |
OS, OS-T3, OS-T4, DFS-T3 |
Foote et al., 20062121 Foote RL, Foote RT, Brown PD, Garces YI, Okuno SH, Strome SE. Organ preservation for advanced laryngeal carcinoma. Head Neck. 2006;28:689-96.
|
101 |
Rec, Tube |
Fuller et al., 20162222 Fuller CD, Mohamed AS, Garden AS, Gunn GB, Mulcahy CF, Zafereo M, et al. Long‐term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches. Head Neck. 2016;38:1739-51.
|
412 |
Disf, Tube |
Gourin et al., 20092323 Gourin CG, Conger BT, Sheils WC, Bilodeau PA, Coleman TA, Porubsky ES. The effect of treatment on survival in patients with advanced laryngeal carcinoma. Laryngoscope. 2009;119:1312-7.
|
264 |
OS-T4 |
Grover et al., 20152424 Grover S, Swisher-McClure S, Mitra N, Li J, Cohen RB, Ahn PH, et al. Total laryngectomy versus larynx preservation for T4a larynx cancer: patterns of care and survival outcomes. Int J Radiat Oncol Biol Phys. 2015;92:594-601.
|
969 |
OS, OS-T4 |
Hsin et al., 20142525 Hsin LJ, Fang TJ, Tsang NM, Chin SC, Yen TC, Li HY, et al. Tumor volumetry as a prognostic factor in the management of T4a laryngeal cancer. Laryngoscope. 2014;124:1134-40.
|
62 |
Rec |
Jones et al., 19922626 Jones AS, Cook JA, Phillips DE, Lluch ES. Treatment of T3 carcinoma of the larynx by surgery or radiotherapy. Clin Otolaryngol. 1992;17:433-6.
|
147 |
Rec |
Karatzanis et al., 20142727 Karatzanis AD, Psychogios G, Waldfahrer F, Kapsreiter M, Zenk J, Velegrakis GA, et al. Management of locally advanced laryngeal cancer. J Otolaryngol Head Neck Surg. 2014;43:4.
|
384 |
Rec |
Lee et al., 20223939 Lee MY, Belfiglio M, Zeng J, Fleming CW, Koyfman S, Joshi NP, et al. Primary Total Laryngectomy versus Organ Preservation for Locally Advanced T3/T4a Laryngeal Cancer. Laryngoscope. 2023;133:1122-31.
|
237 |
DFS-T3, Rec, Dysp, Tube |
Lin et al., 20161414 Lin CC, Fedewa SA, Prickett KK, Higgins KA, Chen AY. Comparative effectiveness of surgical and nonsurgical therapy for advanced laryngeal cancer. Cancer. 2016;122:2845-56.
|
1935 |
OS, DSS, |
Megwalu e Sikora, 20141313 Megwalu UC, Sikora AG. Survival outcomes in advanced laryngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014;140:855-60.
|
5394 |
OS, DSS |
Mulcahy et al., 20182828 Mulcahy CF, Mohamed AS, Kanwar A, Hutcheson KA, Ghosh A, Vock D, et al. Age‐adjusted comorbidity and survival in locally advanced laryngeal cancer. Head Neck. 2018;40:2060-9.
|
548 |
OS, DSS |
Nair et al., 20182929 Nair SV, Mair M, Sawarkar N, Chakrabarti S. Organ preservation vs primary surgery in the management of T3 laryngeal and hypopharyngeal cancers. Eur Arch Otorhinolaryngol. 2018;275:2311-6.
|
120 |
OS, OS-T3, DFS-T3, Rec |
Nocon et al., 20191010 Nocon CC, Yesensky J, Ajmani GS, Bhayani MK. Failed larynx preservation and survival in patients with advanced larynx cancer. Am J Otolaryngol. 2019;40:542-6.
|
3594 |
OS |
Oh et al., 20193030 Oh J, Prisman E, Olson R, Berthelet E, Wu J, Tran E, et al. Primary organ preservation vs total laryngectomy for T4a larynx cancer. Head Neck. 2019;41:3265-75.
|
130 |
OS, OS-T4, DSS, Rec, Tube |
O’Neil et al., 20161515 O'Neill CB, O'Neill JP, Atoria CL, Baxi SS, Henman MC, Ganly I, et al. Treatment Complications and Survival in Advanced Laryngeal Cancer: A Population Based Analysis. Laryngoscope. 2014;124:2707-13.
|
759 |
Tube. |
Patel et al., 20113131 Patel UA, Howell LK. Local response to chemoradiation in T4 larynx cancer with cartilage invasion. Laryngoscope. 2011;121:106-10.
|
34 |
Rec |
Patel et al., 20191212 Patel SA, Qureshi MM, Dyer M A, Jalisi S, Grillone G, Truong MT. Comparing surgical and nonsurgical larynx‐preserving treatments with total laryngectomy for locally advanced laryngeal cancer. Cancer. 2019;125:3367-77.
|
6166 |
OS |
Porter et al., 19983232 Porter MJ, McIvor NP, Morton RP, Hindley AC. Audit in the management of T3 fixed-cord laryngeal cancer. Am J Otolaryngol. 1998;19:360-4.
|
71 |
Rec |
Reizenstein et al., 20143333 Reizenstein JA, Holmberg L, Bergqvist M, Linder A, Ekman S, Lödén B, et al. Time trends in T3 to T4 laryngeal cancer: A population‐based long‐term analysis. Head Neck. 2014;36:1727-31.
|
263 |
OS |
Rosenthal et al., 20153434 Rosenthal DI, Mohamed AS, Weber RS, Garden AS, Sevak PR, Kies MS, et al. Long‐term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3‐decade survey. Cancer. 2015;121:1608-19.
|
221 |
Dysp, Tube. |
Simpson et al., 19933535 Simpson D, Robertson AG, Lamont D. A comparison of radiotherapy and surgery as primary treatment in the management of T3 N0 M0 glottic tumours. J Laryngol Otol. 1993;107:912-5.
|
74 |
OS, OS-T3, Rec |
Spector et al., 20063636 Spector JG, Sessions DG, Lenox J, Simpson J. Management of T3N1 glottic carcinoma: therapeutic outcomes. Laryngoscope. 2006;116:106-10.
|
49 |
Rec, Dysp, Tube |
Timmermans et al., 20143737 Timmermans AJ, de Gooijer CJ, Hamming-Vrieze O, Hilgers FJ, van den Brekel MW. T3‐T4 laryngeal cancer in the Netherlands Cancer Institute; 10‐year results of the consistent application of an organ‐preserving/sacrificing protocol. Head Neck. 2015;37:1495-503.
|
182 |
OS, Rec |
Vengalil et al., 20163838 Vengalil S, Giuliani ME, Huang SH, McNiven A, Song Y, Xu W, et al. Clinical outcomes in patients with T4 laryngeal cancer treated with primary radiotherapy versus primary laryngectomy. Head Neck. 2016;38:E2035-40.
|
107 |
OS, OS-T4, Tube |